TRex Bio files final prospectus for Nasdaq IPO

TRex Bio filed a final prospectus for its IPO, pricing 8,333,334 shares at $14.00 each and expecting gross proceeds of about $116.7 million. The company was approved to list on Nasdaq Global Select Market under ticker TRXB.